BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20200442)

  • 1. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
    Lindström S; Hunter DJ; Grönberg H; Stattin P; Wiklund F; Xu J; Chanock SJ; Hayes R; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):873-6. PubMed ID: 20200442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
    Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
    Stevens VL; Hsing AW; Talbot JT; Zheng SL; Sun J; Chen J; Thun MJ; Xu J; Calle EE; Rodriguez C
    Int J Cancer; 2008 Dec; 123(11):2644-50. PubMed ID: 18752252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
    Cheng I; Plummer SJ; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk.
    Wang X; Xu Z; Miao CH
    Genet Mol Res; 2015 Dec; 14(4):17847-55. PubMed ID: 26782430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.
    Zheng SL; Augustsson-Bälter K; Chang B; Hedelin M; Li L; Adami HO; Bensen J; Li G; Johnasson JE; Turner AR; Adams TS; Meyers DA; Isaacs WB; Xu J; Grönberg H
    Cancer Res; 2004 Apr; 64(8):2918-22. PubMed ID: 15087412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.
    Veltkamp M; van Moorsel CH; Rijkers GT; Ruven HJ; Grutters JC
    Tissue Antigens; 2012 Jan; 79(1):25-32. PubMed ID: 22150367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Toll-like receptor polymorphisms with HIV status in North Americans.
    Willie B; Hall NB; Stein CM; Jurevic RJ; Weinberg A; Mehlotra RK; Zimmerman PA
    Genes Immun; 2014 Dec; 15(8):569-77. PubMed ID: 25253287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant Association between Toll-Like Receptor Gene Polymorphisms and Posttransplantation Diabetes Mellitus.
    Kim JS; Kim SK; Park JY; Kim YG; Moon JY; Lee SH; Ihm CG; Lee TW; Kim SK; Chung JH; Kang SW; Kim TH; Kim YH; Jeong KH
    Nephron; 2016; 133(4):279-86. PubMed ID: 27486667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
    Shui IM; Stark JR; Penney KL; Schumacher FR; Epstein MM; Pitt MJ; Stampfer MJ; Tamimi RM; Lindstrom S; Sesso HD; Fall K; Ma J; Kraft P; Giovannucci E; Mucci LA
    Prostate; 2012 Feb; 72(2):209-16. PubMed ID: 21563195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.
    Kim HJ; Bae JS; Chang IH; Kim KD; Lee J; Shin HD; Lee JY; Kim WJ; Kim W; Myung SC
    World J Urol; 2012 Apr; 30(2):225-32. PubMed ID: 21553150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 region genetic variants are associated with susceptibility to melioidosis.
    West TE; Chierakul W; Chantratita N; Limmathurotsakul D; Wuthiekanun V; Emond MJ; Hawn TR; Peacock SJ; Skerrett SJ
    Genes Immun; 2012 Jan; 13(1):38-46. PubMed ID: 21776015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 subfamily genotypes are not associated with severity of bronchiolitis or postbronchiolitis wheezing in infants.
    Nuolivirta K; Vuononvirta J; Peltola V; Koponen P; Helminen M; He Q; Korppi M
    Acta Paediatr; 2013 Dec; 102(12):1160-4. PubMed ID: 24112285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Polymorphism of Toll-Like Receptors and Lung Function at Five to Seven Years of Age after Infant Bronchiolitis.
    Lauhkonen E; Koponen P; Vuononvirta J; Teräsjärvi J; Nuolivirta K; Toikka JO; Helminen M; He Q; Korppi M
    PLoS One; 2016; 11(1):e0146526. PubMed ID: 26741133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Toll-like receptor polymorphisms in acute pancreatitis occurrence and severity.
    Matas-Cobos AM; Redondo-Cerezo E; Alegría-Motte C; Martínez-Chamorro A; Saenz-López P; Jiménez P; Jiménez MR; González-Calvín JL; de Teresa J; Osuna FR
    Pancreas; 2015 Apr; 44(3):429-33. PubMed ID: 25423559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer.
    Srivastava K; Srivastava A; Kumar A; Mittal B
    Liver Int; 2010 Aug; 30(7):1067-72. PubMed ID: 20492496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.
    Xiao W; Liu Z; Lin J; Li J; Wu K; Ma Y; Gong Y; Liu Z
    Autoimmunity; 2015 Feb; 48(1):13-8. PubMed ID: 25028161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.